Please provide your email address to receive an email when new articles are posted on . Sustained DMARD-free remission “does not seem attainable” for patients with RA requiring biological DMARDs, but ...

rheumatoid arthritis dmard vs biologic Updated American College of Rheumatology recommendations suggest using first-line DMARDs in combination with biologic agents and nonbiologic DMARDs to achieve ...

Nonsteroidal anti-inflammatory drugs and analgesics are frequently prescribed to alleviate symptoms in patients with RA. However, these medications have no impact on disease progression and therefore ...

A study looked at more than 23,600 Medicare beneficiaries with RA who had received a ≥30-day prescription of an opioid drug. Participants were grouped according to those who had been prescribed a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Early, aggressive treatment with a ...

DMARDs are a medication that suppresses the immune system. People may take them to slow disease progression in autoimmune or inflammatory conditions, such as different types of arthritis. Inflammation ...

Early aggressive treatment of rheumatoid arthritis is associated with improved disease control, slower radiological progression and improved functional outcomes. Tumor necrosis factor blocking therapy ...

Two phase III trials of the Janus kinase (JAK) inhibitor tofacitinib have produced favourable results in patients with active rheumatoid arthritis (RA). The studies, which were funded by Pfizer, the ...